The safety profile of Quzyttir was further established in the phase 3 study1

Woman smiling as she leans over paperwork on desk Woman smiling as she leans over paperwork on desk

Adverse reactions for Quzyttir and IV DPH injection1,2

The most common adverse reactions (incidence less than 1%) with Quzyttir include dysgeusia, headache, paresthesia, presyncope, dyspepsia, feeling hot, and hyperhidrosis1
List of adverse reactions of Quzyttir versus DPH injection List of adverse reactions of Quzyttir versus DPH injection
Subjects in the Quzyttir treatment group reported less sedation at all time points compared to IV diphenhydramine1
Subject-rated sedation scores were assessed at baseline, 1 hr, and/or 2 hrs, and/or “Readiness for Discharge”. Sedation was rated on a 0 to 3 scale (0=none, to 3=severe) with lower sedation scores indicating less sedation. Subjects in the Quzyttir treatment group reported less sedation at all time points compared to subjects treated with diphenhydramine.
For more information or to request a rep visit, call 1-8‍66-QUZYTTIR